A'Hern R - Search Results

1

Contribution of germline MLH1 and MSH2 mutations to lobular carcinoma in situ of the breast.

Stone JG, Coleman G, Gusterson B, Marossy A, Lakhani SR, Ward A, Nash A, McKinna A, A'Hern R, Stratton MR, Houlston RS. Stone JG, et al. Cancer Lett. 2001 Jun 26;167(2):171-4. doi: 10.1016/s0304-3835(01)00448-7. Cancer Lett. 2001. PMID: 11369138

2

Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene.

Rahman N, Stone JG, Coleman G, Gusterson B, Seal S, Marossy A, Lakhani SR, Ward A, Nash A, McKinna A, A'Hern R, Stratton MR, Houlston RS. Rahman N, et al. Br J Cancer. 2000 Feb;82(3):568-70. doi: 10.1054/bjoc.1999.0965. Br J Cancer. 2000. PMID: 10682667 Free PMC article.

3

Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone.

Price P, Sinnett HD, Gusterson B, Walsh G, A'Hern RP, McKinna JA. Price P, et al. Br J Cancer. 1990 Jun;61(6):869-72. doi: 10.1038/bjc.1990.194. Br J Cancer. 1990. PMID: 2164835 Free PMC article.

4

Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up.

Badve S, A'Hern RP, Ward AM, Millis RR, Pinder SE, Ellis IO, Gusterson BA, Sloane JP. Badve S, et al. Hum Pathol. 1998 Sep;29(9):915-23. doi: 10.1016/s0046-8177(98)90196-4. Hum Pathol. 1998. PMID: 9744307

5

No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours.

Jefferies S, Edwards SM, Hamoudi RA, A'Hern R, Foulkes W, Goldgar D, Eeles R; MPT Collaborators. Jefferies S, et al. Br J Cancer. 2001 Nov 2;85(9):1383-6. doi: 10.1054/bjoc.2001.2068. Br J Cancer. 2001. PMID: 11720478 Free PMC article.

6

Clinical outcome and service implications of screening women at increased breast cancer risk from a family history.

Gui GP, Kadayaprath G, Darhouse N, Self J, Ward A, A'Hern R, Eeles R. Gui GP, et al. Eur J Surg Oncol. 2006 Sep;32(7):719-24. doi: 10.1016/j.ejso.2006.05.002. Epub 2006 Jun 19. Eur J Surg Oncol. 2006. PMID: 16784834

7

Duct carcinoma-in-situ: can we predict recurrence after surgery?

Price P, Sinnett HD, Gusterson B, Walsh G, A'Hern RP, McKinna JA. Price P, et al. Lancet. 1989 Sep 16;2(8664):671-2. doi: 10.1016/s0140-6736(89)90908-2. Lancet. 1989. PMID: 2570913 No abstract available.

8

The role of genetic factors in predisposition to squamous cell cancer of the head and neck.

Jefferies S, Eeles R, Goldgar D, A'Hern R, Henk JM, Gore M. Jefferies S, et al. Br J Cancer. 1999 Feb;79(5-6):865-7. doi: 10.1038/sj.bjc.6690138. Br J Cancer. 1999. PMID: 10070882 Free PMC article. Review.

9

Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.

Gui GP, Joubert DJ, Reichert R, Ward A, Lakhani S, Osin P, Nerurkar A, A'Hern R, Benson K, Underwood SR. Gui GP, et al. Eur J Surg Oncol. 2005 Sep;31(7):707-14. doi: 10.1016/j.ejso.2005.04.014. Eur J Surg Oncol. 2005. PMID: 15993028

10

Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval.

Fong PC, Yap TA, Boss DS, Carden CP, Mergui-Roelvink M, Gourley C, De Greve J, Lubinski J, Shanley S, Messiou C, A'Hern R, Tutt A, Ashworth A, Stone J, Carmichael J, Schellens JH, de Bono JS, Kaye SB. Fong PC, et al. J Clin Oncol. 2010 May 20;28(15):2512-9. doi: 10.1200/JCO.2009.26.9589. Epub 2010 Apr 20. J Clin Oncol. 2010. PMID: 20406929 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters